Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders

 
 

Repare Therapeutics Inc. (RPTX) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10y
Price: $20.95 Metrics
OS: 42.1 M -38 % ROE
Market cap: $882 M -68 % ROIC
Net cash: $116 M $2.74 per share
EV: $766 M

 
TTM Valuation
EBITDA
EBIT ($80.3) M
EPS ($2.23)

Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17
Revenues0.00.00.012.86.2
            Revenue growth  -100.0%107.6% 
Cost of goods sold0.00.00.012.86.2
Gross profit0.00.00.00.00.0
            Gross margin   0.0%0.0%
Selling, general and administrative116.354.426.4  
General and administrative   2.91.8
EBIT-108.5-55.2-27.7-12.8-6.2
            EBIT margin   -100.0%-100.0%
Pre-tax income-108.6-54.7-27.0-14.2-7.8
Income taxes-1.7-1.30.20.00.0
            Tax rate1.5%2.4% 0.2%0.0%
Net income0.00.00.00.00.0
            Net margin   0.0%0.0%
 
Diluted EPS$0.00$0.00$0.00  
Shares outstanding (diluted)37.820.01.5  
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy